Related Experiment Video
Updated: Aug 24, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific
Alice Arapshian1, Silvina Bertran, Yuvarani S Kuppumbatti
1Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029-6574, USA. aa74ny@yahoo.com
Background:
The cellular retinol binding protein I gene (CRBP) is downregulated in a subset of human breast cancers and in MMTV-Myc induced mouse mammary tumors. Functional studies suggest that CRBP downregulation contributes to breast tumor progression. What is the mechanism underlying CRBP downregulation in cancer? Here we investigated the hypothesis that CRBP is epigenetically silenced through DNA hypermethylation in human and mouse breast cancer.
Results:
Bisulfite sequencing of CRBP in a panel of 6 human breast cancer cell lines demonstrated that, as a rule, CRBP hypermethylation is closely and inversely related to CRBP expression and identified one exception to this rule. Treatment with 5-azacytidine, a DNA methyltransferase inhibitor, led to CRBP reexpression, supporting the hypothesis that CRBP hypermethylation is a proximal cause of CRBP silencing. In some cells CRBP reexpression was potentiated by co-treatment with retinoic acid, an inducer of CRBP, and trichostatin A, a histone deacetylase inhibitor. Southern blot analysis of a small panel of human breast cancer specimens identified one case characterized by extensive CRBP hypermethylation, in association with undetectable CRBP mRNA and protein. Bisulfite sequencing of CRBP in MMTV-Myc and MMTV-Neu/NT mammary tumor cell lines extended the rule of CRBP hypermethylation and silencing (both seen in MMTV-Myc but not MMTV-Neu/NT cells) from human to mouse breast cancer and suggested that CRBP hypermethylation is an oncogene-specific event.
Conclusion:
CRBP hypermethylation appears to be an evolutionarily conserved and principal mechanism of CRBP silencing in breast cancer. Based on the analysis of transgenic mouse mammary tumor cells, we hypothesize that CRBP silencing in human breast cancer may be associated with a specific oncogenic signature.
Insights
Cellular retinol binding protein I (CRBP) is epigenetically silenced by DNA hypermethylation in breast cancer. This conserved mechanism contributes to tumor progression and may be linked to specific oncogenes.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cellular retinol binding protein I (CRBP) gene downregulation is observed in human breast cancers and mouse models.
- CRBP downregulation is implicated in breast tumor progression.
- The epigenetic mechanisms driving CRBP silencing in cancer remain largely unknown.
Purpose of the Study:
- To investigate the hypothesis that CRBP is epigenetically silenced through DNA hypermethylation in human and mouse breast cancer.
- To determine the relationship between CRBP hypermethylation and CRBP expression.
- To explore potential therapeutic strategies for reversing CRBP silencing.
Main Methods:
- Bisulfite sequencing of the CRBP gene in human breast cancer cell lines and mouse mammary tumor cell lines.
- Treatment with 5-azacytidine (DNA methyltransferase inhibitor) and trichostatin A (histone deacetylase inhibitor).
- Southern blot analysis of human breast cancer specimens.
Main Results:
- CRBP hypermethylation was inversely correlated with CRBP expression in most human breast cancer cell lines.
- 5-azacytidine treatment restored CRBP expression, confirming DNA hypermethylation as a cause of silencing.
- CRBP hypermethylation and silencing were observed in MMTV-Myc mouse models, suggesting an oncogene-specific event.
Conclusions:
- CRBP hypermethylation is a conserved and primary mechanism for CRBP gene silencing in breast cancer.
- CRBP silencing in human breast cancer may be associated with specific oncogenic signatures.
- Targeting epigenetic modifications offers potential therapeutic avenues for breast cancer treatment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cell Specific Gene Expression
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Master Transcription Regulators
